C
Christine S. Cheng
Researcher at Boston University
Publications - 31
Citations - 3522
Christine S. Cheng is an academic researcher from Boston University. The author has contributed to research in topics: Transcription factor & Regulation of gene expression. The author has an hindex of 17, co-authored 31 publications receiving 3068 citations. Previous affiliations of Christine S. Cheng include Broad Institute & University of California, San Diego.
Papers
More filters
Journal ArticleDOI
Higher-Order Inter-chromosomal Hubs Shape 3D Genome Organization in the Nucleus
Sofia A. Quinodoz,Noah Ollikainen,Barbara Tabak,Ali Palla,Jan Marten Schmidt,Elizabeth Detmar,Mason Lai,Alexander A. Shishkin,Prashant Bhat,Prashant Bhat,Yodai Takei,Vickie Trinh,Erik Aznauryan,Pamela Russell,Christine S. Cheng,Marko Jovanovic,Amy Y. M. Chow,Long Cai,Patrick McDonel,Manuel Garber,Mitchell Guttman +20 more
TL;DR: This work develops split-pool recognition of interactions by tag extension (SPRITE), a method that enables genome-wide detection of higher-order interactions within the nucleus and generates a global model whereby nuclear bodies act as inter-chromosomal hubs that shape the overall packaging of DNA in the nucleus.
Journal ArticleDOI
A Unifying Model for the Selective Regulation of Inducible Transcription By CpG Islands and Nucleosome Remodeling
Vladimir R. Ramirez-Carrozzi,Daniel Braas,Dev M. Bhatt,Christine S. Cheng,Christine Hong,Kevin R. Doty,Joshua C. Black,Alexander Hoffmann,Michael Carey,Stephen T. Smale +9 more
TL;DR: A broad mechanistic framework for the transcriptional induction of mammalian primary response genes by Toll-like receptors and other stimuli is described, which includes CpG-island promoters, which facilitate promiscuous induction from constitutively active chromatin without a requirement for SWI/SNF nucleosome remodeling complexes.
Journal ArticleDOI
Histone methylation-dependent mechanisms impose ligand dependency for gene activation by nuclear receptors.
Ivan Garcia-Bassets,Young-Soo Kwon,Francesca Telese,Gratien G. Prefontaine,Kasey R. Hutt,Christine S. Cheng,Bong-Gun Ju,Kenneth A. Ohgi,Jianxun Wang,Laure Escoubet-Lozach,David W. Rose,Christopher K. Glass,Xiang-Dong Fu,Michael G. Rosenfeld +13 more
TL;DR: An unexpected and general strategy that is based on the requirement for specific cohorts of inhibitory histone methyltransferases to impose gene-specific gatekeeper functions that prevent unliganded nuclear receptors and other classes of regulated transcription factors from binding to their target gene promoters and causing constitutive gene activation in the absence of stimulating signals is reported.
Journal ArticleDOI
A high throughput Chromatin ImmunoPrecipitation approach reveals principles of dynamic gene regulation in mammals
Manuel Garber,Nir Yosef,Nir Yosef,Alon Goren,Raktima Raychowdhury,Anne Thielke,Mitchell Guttman,Mitchell Guttman,James T. Robinson,Brian Minie,Nicolas Chevrier,Zohar Itzhaki,Ronnie Blecher-Gonen,Chamutal Bornstein,Daniela Amann-Zalcenstein,Assaf Weiner,Dennis C. Friedrich,James Meldrim,Oren Ram,Christine S. Cheng,Christine S. Cheng,Andreas Gnirke,Sheila Fisher,Nir Friedman,Bang Wong,Bradley E. Bernstein,Bradley E. Bernstein,Chad Nusbaum,Nir Hacohen,Nir Hacohen,Aviv Regev,Aviv Regev,Aviv Regev,Ido Amit,Ido Amit +34 more
TL;DR: Chang et al. as mentioned in this paper developed a high-throughput Chromatin ImmunoPrecipitation (HT-ChIP) method to systematically map protein-DNA interactions to define the dynamics of DNA binding by 25 transcription factors and 4 chromatin marks at 4 time-points following pathogen stimulus of dendritic cells.
Journal ArticleDOI
Akt and Autophagy Cooperate to Promote Survival of Drug-Resistant Glioma
Qi-Wen Fan,Christine S. Cheng,Christopher S. Hackett,Morri E. Feldman,Benjamin T. Houseman,Theodore Nicolaides,Daphne A. Haas-Kogan,C. David James,Scott A. Oakes,Jayanta Debnath,Kevan M. Shokat,William A. Weiss +11 more
TL;DR: The dual PI3K-mTOR inhibitor PI-103 induces autophagy in a form of glioma that is resistant to therapy, and elicited cell death with combinations of drugs that are either now in use in patients or in clinical trials, raising the hope that this approach could be readily translatable to human therapy.